A comprehensive review of the effects of tacrolimus (FK-506) on dry eye disease (DED): Focus on inflammation and biochemical processes
Maryam Golmohammadi,
Mehraveh Sadeghi Ivraghi,
Saade Abdalkareem Jasim
et al.
Abstract:Dry eye disease (DED) represents a prevalent visual ailment, defined by
insufficient wetting and lubrication of the ocular surface. The
principal management strategy for dry eye involves the application of
artificial tear solutions to mitigate eye discomfort. Moreover,
immune-modulating agents such as cyclosporine A and tacrolimus (FK506)
are employed in the therapeutic regimen for this condition. These drugs
regulate the immune response and reduce ocular inflammation. Tacrolimus
(TAC) is 10-100 times more eff… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.